Halozyme Appoints Barbara Duncan to its Board of Directors

Go back to Halozyme Appoints Barbara Duncan to its Board of Directors
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.56 -1.33 (1.18%)
Previous Close $112.89    52 Week High $18.39 
Open $112.89    52 Week Low $6.96 
Day High $114.52    P/E N/A 
Day Low $111.03    EPS $-0.58 
Volume 2,873,064